Similar Search Results

¿Los medios de comunicación en Colombia son una industria creadora de valor?

Godoy, Jorge Alberto Rivera; Ospina, Ana Milena Padilla - In: REVISTA FINANZAS Y POLÍTICA ECONÓMICA (2013)

2006-2011 is made using financial indicators that assess growth, efficiency, effectiveness, efficiency, economic value … study, showing a high dependence on the effectiveness with which the sector has managed administrative expenses and …

Persistent link: https://www.econbiz.de/10010945806

How much do we know about the long-term effectiveness of parenting programmes? Advances, shortcomings, and future directions

Özdemir, Metin - In: Journal of Children's Services 10 (2015) 2, pp. 120-132

Purpose – Parenting programmes are seen as feasible and cost-effective in preventing early behavioural problems in children and adolescents. A number of studies have concluded that such programmes are effective in reducing child problem behaviours and improving the skills and well-being of...

Persistent link: https://www.econbiz.de/10014852702

Comparative assessment of policies targeting energy use efficiency in Lithuania

Streimikiene, Dalia; Volochovic, Andzej; Simanaviciene, … - In: Renewable and Sustainable Energy Reviews 16 (2012) 6, pp. 3613-3620

targeting energy intensity decrease in Lithuania in terms of efficiency, effectiveness and efficacy and to select the best …

Persistent link: https://www.econbiz.de/10010664502

A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe

Campillo-Artero, Carlos - In: Health Policy 113 (2013) 1, pp. 38-44

The unacceptably high incidence of clinical adverse events caused by medical devices (MDs), their high recall rates, and the frequent phase out of some of the devices that pose a greater risk to health have triggered alarm concerning the long-standing weaknesses of their regulatory processes. It...

Persistent link: https://www.econbiz.de/10010719296

Itsehoitolääkkeiden kaupan vapauttamisen merkitys kuluttajille ja kaupalle

Mankinen, Reijo; Rantala, Olavi - 2009

Persistent link: https://www.econbiz.de/10010272985

Itsehoitolääkkeiden kaupan vapauttamisen merkitys kaupalle ja kuluttajille

Mankinen, Reijo; Rantala, Olavi - Elinkeinoelämän Tutkimuslaitos (ETLA) - 2009

Lääkemarkkinoita on vapautettu viime vuosina muissa Pohjoismaissa. Norjassa, Tanskassa ja Ruotsissa itsehoitolääkkeiden myynti on sallittu apteekkien lisäksi päivittäistavarakaupalle. Norjassa ja Ruotsissa on vapautettu lääkemarkkinoita laajemminkin. Myös Suomessa on käyty keskustelua...

Persistent link: https://www.econbiz.de/10008549315

Itsehoitolääkkeiden kaupan vapauttamisen merkitys kuluttajille ja kaupalle

Mankinen, Reijo; Rantala, Olavi - 2009

Persistent link: https://www.econbiz.de/10003898529

Organizational powers : capture of professional jurisdiction in the case of US retail clinics

Galperin, Roman V. - 2011

Innovative technology may reduce organizations’ reliance on professionals in the performance of expert tasks, weakening professions’ control over work. However, professions resist and challenge such innovation, framing it as unsafe and immoral. This paper theorizes a process by which...

Persistent link: https://www.econbiz.de/10009580343

The Use of Mtas to Control Commercialization of Stem Cell Diagnostics and Therapeutics

O'Connor, Sean M. - 2013

While much of the commentary on obstacles to stem cell research focuses on patents, material transfer agreements (MTAs) governed by state contract and property law present equal if not greater challenges to researchers. This Article argues that the life sciences in general, and the stem cell...

Persistent link: https://www.econbiz.de/10012754166

Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy

Michaeli, Daniel Tobias; Michaeli, Thomas; Albers, Sebastian - In: The European Journal of Health Economics 25 (2023) 6, pp. 979-997

’s five special designations for drug development regarding their safety, efficacy/clinical benefit, clinical trials … breakthrough therapy) on the safety, efficacy/clinical benefit, trials, innovativeness, economic incentives, development times, and … for this uncertainty in clinical trial evidence and cost-effectiveness, the pricing and reimbursement of these drugs …

Persistent link: https://www.econbiz.de/10015328830